Simplex Trading
CTXR icon

Simplex Trading’s Citius Pharmaceuticals CTXR Stock Holding History

Simplex Trading’s Portfolio CTXR Stock Details CTXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$759 Buy
+1,256
New +$850 ﹤0.01% 8883
2025
Q4 		– Sell
-9,556
Closed -$11K – 8811
2025
Q3 		$11K Buy
+9,556
New +$13.3K ﹤0.01% 7803
2025
Q2 		– Sell
-966
Closed -$1K – 8806
2025
Q1 		$1K Sell
966
-754
-44% -$1.8K ﹤0.01% 8179
2024
Q4 		$6K Buy
1,720
+1,378
+403% +$9.28K ﹤0.01% 7487
2024
Q3 		$4K Sell
342
-84
-20% -$1.41K ﹤0.01% 7695
2024
Q2 		$6K Buy
426
+137
+47% +$2.46K ﹤0.01% 7741
2024
Q1 		$6K Sell
289
-1,391
-83% -$25.4K ﹤0.01% 7898
2023
Q4 		$31K Buy
1,680
+597
+55% +$11.3K ﹤0.01% 6528
2023
Q3 		$18K Buy
+1,083
New +$25.7K ﹤0.01% 6699
2022
Q3 		– Sell
-1,694
Closed -$46.6K – 10040
2022
Q2 		$38K Buy
1,694
+1,068
+171% +$29.3K ﹤0.01% 6841
2022
Q1 		$28K Buy
626
+594
+1,856% +$23.5K ﹤0.01% 7837
2021
Q4 		$1K Sell
32
-924
-97% -$41.9K ﹤0.01% 10162
2021
Q3 		$62K Buy
+956
New +$48K ﹤0.01% 7258

Other funds holding CTXR

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MFS
Miller Financial Services Marshall, Michigan $124M AUM 17.62% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
AAG
Asset Advisory Group Kinnelon, New Jersey $229M AUM

Simplex Trading's CTXR Position: Q2 2026 in Review

Simplex Trading opened a new position in Citius Pharmaceuticals (CTXR) in Q2 2026: 1,256 shares worth $759. The stake represents ﹤0.01% of the portfolio and ranks #8883 among its holdings. This is a return to the name: Simplex Trading previously reported a position in CTXR as recently as Q3 2025.

Simplex Trading first reported a position in CTXR in Q3 2021 and has held it in 13 quarters since. The position peaked at $62K in Q3 2021. 43 funds tracked by Wall St. Rank hold CTXR as of Q2 2026.

  • Simplex Trading held 1,256 shares of Citius Pharmaceuticals worth $759 as of Q2 2026.
  • Citius Pharmaceuticals was a new Simplex Trading position in Q2 2026.
  • Citius Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #8883 holding.
  • Simplex Trading first reported a position in Citius Pharmaceuticals in Q3 2021 and has held it in 13 quarters since.
  • Simplex Trading's Citius Pharmaceuticals position peaked at $62K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Citius Pharmaceuticals as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.